Technosphere Insulin Inhalation Powder

DRUG6 trials

Sponsors

Mannkind Corporation

Conditions

AsthmaDiabetes MellitusDiabetes Type 2Type 1 DiabetesType 1 Diabetes MellitusType 2 DiabetesType 2 Diabetes Mellitus

Phase 1

A Study Designed to Determine if the Pharmacokinetic Disposition of Inhaled Insulin Exposure is the Same for Asthmatics and Non-asthmatics

CompletedNCT00673621

Mannkind CorporationAsthma, Diabetes Mellitus

Start: 2008-05-31End: 2008-12-31Updated: 2012-06-13

Comparison of Technosphere Insulin Inhalation Powder & Subcutaneous Rapid-Acting Analog in Subjects With Type 1 Diabetes

CompletedNCT01544881

Mannkind CorporationType 1 Diabetes Mellitus

Start: 2012-03-31End: 2013-01-31Updated: 2013-01-25

Phase 2

Clamp Study Comparing Inhalation of Technosphere®/Insulin in Smokers and Non-Smokers With Type 2 Diabetes

CompletedNCT00934414

Mannkind CorporationDiabetes Type 2

Start: 2004-08-31End: 2006-09-30Updated: 2009-07-08

Unknown Phase

A 2-Month Safety Follow-Up Trial

CompletedNCT00741429

Mannkind CorporationType 1 Diabetes, Type 2 Diabetes

Start: 2007-05-31End: 2008-09-30Updated: 2014-12-03

Pulmonary Function Substudy for Subjects Enrolled in Studies MKC-TI-161, MKC-TI-162 or MKC-TI-166

TerminatedNCT01201928

Mannkind CorporationType 1 Diabetes Mellitus, Type 2 Diabetes Mellitus

Start: 2010-10-31End: 2012-03-31Updated: 2012-12-06

Patient Transitioning From Exubera® Inhalation Powder to Technosphere® Insulin Inhalation Powder

Mannkind CorporationType 1 Diabetes, Type 2 Diabetes

Start: 2008-10-31End: 2015-05-31Updated: 2016-01-20